Global Icatibant Acetate Injection Market Growth 2026-2032
The global Icatibant Acetate Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Icatibant acetate injection is a synthetic bradykinin B2 receptor antagonist used to treat acute attacks of hereditary angioedema (HAE). Administered subcutaneously, icatibant provides rapid relief from symptoms like facial, throat, or abdominal swelling, and is a key treatment option for managing acute HAE attacks.
United States market for Icatibant Acetate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Icatibant Acetate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Icatibant Acetate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Icatibant Acetate Injection players cover Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Icatibant Acetate Injection Industry Forecast? looks at past sales and reviews total world Icatibant Acetate Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Icatibant Acetate Injection sales for 2026 through 2032. With Icatibant Acetate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Icatibant Acetate Injection industry.
This Insight Report provides a comprehensive analysis of the global Icatibant Acetate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Icatibant Acetate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Icatibant Acetate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Icatibant Acetate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Icatibant Acetate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Icatibant Acetate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Icatibant Acetate Injection market?
What factors are driving Icatibant Acetate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Icatibant Acetate Injection market opportunities vary by end market size?
How does Icatibant Acetate Injection break out by Type, by Application?
Icatibant acetate injection is a synthetic bradykinin B2 receptor antagonist used to treat acute attacks of hereditary angioedema (HAE). Administered subcutaneously, icatibant provides rapid relief from symptoms like facial, throat, or abdominal swelling, and is a key treatment option for managing acute HAE attacks.
United States market for Icatibant Acetate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Icatibant Acetate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Icatibant Acetate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Icatibant Acetate Injection players cover Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Icatibant Acetate Injection Industry Forecast? looks at past sales and reviews total world Icatibant Acetate Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Icatibant Acetate Injection sales for 2026 through 2032. With Icatibant Acetate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Icatibant Acetate Injection industry.
This Insight Report provides a comprehensive analysis of the global Icatibant Acetate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Icatibant Acetate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Icatibant Acetate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Icatibant Acetate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Icatibant Acetate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Icatibant Acetate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Original Drug
- Generic Drug
- Hospital and Clinic
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceuticals
- Eugia Pharma Specialities
- Glenmark Pharmaceuticals
- Sandoz
- Cipla
- Fresenius Kabi
- Jiangsu Hengrui Pharmaceuticals
- Chengdu Shengnuo Biology Pharmacy
What is the 10-year outlook for the global Icatibant Acetate Injection market?
What factors are driving Icatibant Acetate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Icatibant Acetate Injection market opportunities vary by end market size?
How does Icatibant Acetate Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Icatibant Acetate Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Icatibant Acetate Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Icatibant Acetate Injection by Country/Region, 2021, 2025 & 2032
2.2 Icatibant Acetate Injection Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Icatibant Acetate Injection Sales by Type
2.2.3.1 Global Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Icatibant Acetate Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Icatibant Acetate Injection Sale Price by Type (2021-2026)
2.3 Icatibant Acetate Injection Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Icatibant Acetate Injection Sales by Application
2.3.4.1 Global Icatibant Acetate Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Icatibant Acetate Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Icatibant Acetate Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Icatibant Acetate Injection Breakdown Data by Company
3.1.1 Global Icatibant Acetate Injection Annual Sales by Company (2021-2026)
3.1.2 Global Icatibant Acetate Injection Sales Market Share by Company (2021-2026)
3.2 Global Icatibant Acetate Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Icatibant Acetate Injection Revenue by Company (2021-2026)
3.2.2 Global Icatibant Acetate Injection Revenue Market Share by Company (2021-2026)
3.3 Global Icatibant Acetate Injection Sale Price by Company
3.4 Key Manufacturers Icatibant Acetate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Icatibant Acetate Injection Product Location Distribution
3.4.2 Players Icatibant Acetate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ICATIBANT ACETATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Icatibant Acetate Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Icatibant Acetate Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Icatibant Acetate Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Icatibant Acetate Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Icatibant Acetate Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Icatibant Acetate Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Icatibant Acetate Injection Sales Growth
4.4 APAC Icatibant Acetate Injection Sales Growth
4.5 Europe Icatibant Acetate Injection Sales Growth
4.6 Middle East & Africa Icatibant Acetate Injection Sales Growth
5 AMERICAS
5.1 Americas Icatibant Acetate Injection Sales by Country
5.1.1 Americas Icatibant Acetate Injection Sales by Country (2021-2026)
5.1.2 Americas Icatibant Acetate Injection Revenue by Country (2021-2026)
5.2 Americas Icatibant Acetate Injection Sales by Type (2021-2026)
5.3 Americas Icatibant Acetate Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Icatibant Acetate Injection Sales by Region
6.1.1 APAC Icatibant Acetate Injection Sales by Region (2021-2026)
6.1.2 APAC Icatibant Acetate Injection Revenue by Region (2021-2026)
6.2 APAC Icatibant Acetate Injection Sales by Type (2021-2026)
6.3 APAC Icatibant Acetate Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Icatibant Acetate Injection by Country
7.1.1 Europe Icatibant Acetate Injection Sales by Country (2021-2026)
7.1.2 Europe Icatibant Acetate Injection Revenue by Country (2021-2026)
7.2 Europe Icatibant Acetate Injection Sales by Type (2021-2026)
7.3 Europe Icatibant Acetate Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Icatibant Acetate Injection by Country
8.1.1 Middle East & Africa Icatibant Acetate Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Icatibant Acetate Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Icatibant Acetate Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Icatibant Acetate Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Icatibant Acetate Injection
10.3 Manufacturing Process Analysis of Icatibant Acetate Injection
10.4 Industry Chain Structure of Icatibant Acetate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Icatibant Acetate Injection Distributors
11.3 Icatibant Acetate Injection Customer
12 WORLD FORECAST REVIEW FOR ICATIBANT ACETATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Icatibant Acetate Injection Market Size Forecast by Region
12.1.1 Global Icatibant Acetate Injection Forecast by Region (2027-2032)
12.1.2 Global Icatibant Acetate Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Icatibant Acetate Injection Forecast by Type (2027-2032)
12.7 Global Icatibant Acetate Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 Eugia Pharma Specialities
13.2.1 Eugia Pharma Specialities Company Information
13.2.2 Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolios and Specifications
13.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eugia Pharma Specialities Main Business Overview
13.2.5 Eugia Pharma Specialities Latest Developments
13.3 Glenmark Pharmaceuticals
13.3.1 Glenmark Pharmaceuticals Company Information
13.3.2 Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
13.3.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Glenmark Pharmaceuticals Main Business Overview
13.3.5 Glenmark Pharmaceuticals Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Icatibant Acetate Injection Product Portfolios and Specifications
13.4.3 Sandoz Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Icatibant Acetate Injection Product Portfolios and Specifications
13.5.3 Cipla Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Fresenius Kabi
13.6.1 Fresenius Kabi Company Information
13.6.2 Fresenius Kabi Icatibant Acetate Injection Product Portfolios and Specifications
13.6.3 Fresenius Kabi Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Fresenius Kabi Main Business Overview
13.6.5 Fresenius Kabi Latest Developments
13.7 Jiangsu Hengrui Pharmaceuticals
13.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.7.2 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
13.7.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.7.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.8 Chengdu Shengnuo Biology Pharmacy
13.8.1 Chengdu Shengnuo Biology Pharmacy Company Information
13.8.2 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolios and Specifications
13.8.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chengdu Shengnuo Biology Pharmacy Main Business Overview
13.8.5 Chengdu Shengnuo Biology Pharmacy Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Icatibant Acetate Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Icatibant Acetate Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Icatibant Acetate Injection by Country/Region, 2021, 2025 & 2032
2.2 Icatibant Acetate Injection Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Icatibant Acetate Injection Sales by Type
2.2.3.1 Global Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Icatibant Acetate Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Icatibant Acetate Injection Sale Price by Type (2021-2026)
2.3 Icatibant Acetate Injection Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Icatibant Acetate Injection Sales by Application
2.3.4.1 Global Icatibant Acetate Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Icatibant Acetate Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Icatibant Acetate Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Icatibant Acetate Injection Breakdown Data by Company
3.1.1 Global Icatibant Acetate Injection Annual Sales by Company (2021-2026)
3.1.2 Global Icatibant Acetate Injection Sales Market Share by Company (2021-2026)
3.2 Global Icatibant Acetate Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Icatibant Acetate Injection Revenue by Company (2021-2026)
3.2.2 Global Icatibant Acetate Injection Revenue Market Share by Company (2021-2026)
3.3 Global Icatibant Acetate Injection Sale Price by Company
3.4 Key Manufacturers Icatibant Acetate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Icatibant Acetate Injection Product Location Distribution
3.4.2 Players Icatibant Acetate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ICATIBANT ACETATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Icatibant Acetate Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Icatibant Acetate Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Icatibant Acetate Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Icatibant Acetate Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Icatibant Acetate Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Icatibant Acetate Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Icatibant Acetate Injection Sales Growth
4.4 APAC Icatibant Acetate Injection Sales Growth
4.5 Europe Icatibant Acetate Injection Sales Growth
4.6 Middle East & Africa Icatibant Acetate Injection Sales Growth
5 AMERICAS
5.1 Americas Icatibant Acetate Injection Sales by Country
5.1.1 Americas Icatibant Acetate Injection Sales by Country (2021-2026)
5.1.2 Americas Icatibant Acetate Injection Revenue by Country (2021-2026)
5.2 Americas Icatibant Acetate Injection Sales by Type (2021-2026)
5.3 Americas Icatibant Acetate Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Icatibant Acetate Injection Sales by Region
6.1.1 APAC Icatibant Acetate Injection Sales by Region (2021-2026)
6.1.2 APAC Icatibant Acetate Injection Revenue by Region (2021-2026)
6.2 APAC Icatibant Acetate Injection Sales by Type (2021-2026)
6.3 APAC Icatibant Acetate Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Icatibant Acetate Injection by Country
7.1.1 Europe Icatibant Acetate Injection Sales by Country (2021-2026)
7.1.2 Europe Icatibant Acetate Injection Revenue by Country (2021-2026)
7.2 Europe Icatibant Acetate Injection Sales by Type (2021-2026)
7.3 Europe Icatibant Acetate Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Icatibant Acetate Injection by Country
8.1.1 Middle East & Africa Icatibant Acetate Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Icatibant Acetate Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Icatibant Acetate Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Icatibant Acetate Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Icatibant Acetate Injection
10.3 Manufacturing Process Analysis of Icatibant Acetate Injection
10.4 Industry Chain Structure of Icatibant Acetate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Icatibant Acetate Injection Distributors
11.3 Icatibant Acetate Injection Customer
12 WORLD FORECAST REVIEW FOR ICATIBANT ACETATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Icatibant Acetate Injection Market Size Forecast by Region
12.1.1 Global Icatibant Acetate Injection Forecast by Region (2027-2032)
12.1.2 Global Icatibant Acetate Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Icatibant Acetate Injection Forecast by Type (2027-2032)
12.7 Global Icatibant Acetate Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 Eugia Pharma Specialities
13.2.1 Eugia Pharma Specialities Company Information
13.2.2 Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolios and Specifications
13.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eugia Pharma Specialities Main Business Overview
13.2.5 Eugia Pharma Specialities Latest Developments
13.3 Glenmark Pharmaceuticals
13.3.1 Glenmark Pharmaceuticals Company Information
13.3.2 Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
13.3.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Glenmark Pharmaceuticals Main Business Overview
13.3.5 Glenmark Pharmaceuticals Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Icatibant Acetate Injection Product Portfolios and Specifications
13.4.3 Sandoz Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Icatibant Acetate Injection Product Portfolios and Specifications
13.5.3 Cipla Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Fresenius Kabi
13.6.1 Fresenius Kabi Company Information
13.6.2 Fresenius Kabi Icatibant Acetate Injection Product Portfolios and Specifications
13.6.3 Fresenius Kabi Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Fresenius Kabi Main Business Overview
13.6.5 Fresenius Kabi Latest Developments
13.7 Jiangsu Hengrui Pharmaceuticals
13.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.7.2 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
13.7.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.7.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.8 Chengdu Shengnuo Biology Pharmacy
13.8.1 Chengdu Shengnuo Biology Pharmacy Company Information
13.8.2 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolios and Specifications
13.8.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chengdu Shengnuo Biology Pharmacy Main Business Overview
13.8.5 Chengdu Shengnuo Biology Pharmacy Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Icatibant Acetate Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Icatibant Acetate Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Table 7. Global Icatibant Acetate Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Icatibant Acetate Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Icatibant Acetate Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Icatibant Acetate Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Icatibant Acetate Injection Sale Market Share by Application (2021-2026)
Table 12. Global Icatibant Acetate Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Icatibant Acetate Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Icatibant Acetate Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Icatibant Acetate Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Icatibant Acetate Injection Sales Market Share by Company (2021-2026)
Table 17. Global Icatibant Acetate Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Icatibant Acetate Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Icatibant Acetate Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Icatibant Acetate Injection Producing Area Distribution and Sales Area
Table 21. Players Icatibant Acetate Injection Products Offered
Table 22. Icatibant Acetate Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Icatibant Acetate Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Icatibant Acetate Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Icatibant Acetate Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Icatibant Acetate Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Icatibant Acetate Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Icatibant Acetate Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Icatibant Acetate Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Icatibant Acetate Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Icatibant Acetate Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Icatibant Acetate Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Icatibant Acetate Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Icatibant Acetate Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Icatibant Acetate Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Icatibant Acetate Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Icatibant Acetate Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Icatibant Acetate Injection
Table 52. Key Market Challenges & Risks of Icatibant Acetate Injection
Table 53. Key Industry Trends of Icatibant Acetate Injection
Table 54. Icatibant Acetate Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Icatibant Acetate Injection Distributors List
Table 57. Icatibant Acetate Injection Customer List
Table 58. Global Icatibant Acetate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Icatibant Acetate Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Icatibant Acetate Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Icatibant Acetate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Icatibant Acetate Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Icatibant Acetate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Icatibant Acetate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Icatibant Acetate Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Icatibant Acetate Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Icatibant Acetate Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Icatibant Acetate Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Takeda Pharmaceuticals Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
Table 74. Takeda Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Takeda Pharmaceuticals Main Business
Table 76. Takeda Pharmaceuticals Latest Developments
Table 77. Eugia Pharma Specialities Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolios and Specifications
Table 79. Eugia Pharma Specialities Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Eugia Pharma Specialities Main Business
Table 81. Eugia Pharma Specialities Latest Developments
Table 82. Glenmark Pharmaceuticals Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
Table 84. Glenmark Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Glenmark Pharmaceuticals Main Business
Table 86. Glenmark Pharmaceuticals Latest Developments
Table 87. Sandoz Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Sandoz Icatibant Acetate Injection Product Portfolios and Specifications
Table 89. Sandoz Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sandoz Main Business
Table 91. Sandoz Latest Developments
Table 92. Cipla Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Cipla Icatibant Acetate Injection Product Portfolios and Specifications
Table 94. Cipla Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Cipla Main Business
Table 96. Cipla Latest Developments
Table 97. Fresenius Kabi Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Fresenius Kabi Icatibant Acetate Injection Product Portfolios and Specifications
Table 99. Fresenius Kabi Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Fresenius Kabi Main Business
Table 101. Fresenius Kabi Latest Developments
Table 102. Jiangsu Hengrui Pharmaceuticals Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
Table 104. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Jiangsu Hengrui Pharmaceuticals Main Business
Table 106. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 107. Chengdu Shengnuo Biology Pharmacy Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolios and Specifications
Table 109. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Chengdu Shengnuo Biology Pharmacy Main Business
Table 111. Chengdu Shengnuo Biology Pharmacy Latest Developments
Table 1. Icatibant Acetate Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Icatibant Acetate Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Table 7. Global Icatibant Acetate Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Icatibant Acetate Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Icatibant Acetate Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Icatibant Acetate Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Icatibant Acetate Injection Sale Market Share by Application (2021-2026)
Table 12. Global Icatibant Acetate Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Icatibant Acetate Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Icatibant Acetate Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Icatibant Acetate Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Icatibant Acetate Injection Sales Market Share by Company (2021-2026)
Table 17. Global Icatibant Acetate Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Icatibant Acetate Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Icatibant Acetate Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Icatibant Acetate Injection Producing Area Distribution and Sales Area
Table 21. Players Icatibant Acetate Injection Products Offered
Table 22. Icatibant Acetate Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Icatibant Acetate Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Icatibant Acetate Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Icatibant Acetate Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Icatibant Acetate Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Icatibant Acetate Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Icatibant Acetate Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Icatibant Acetate Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Icatibant Acetate Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Icatibant Acetate Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Icatibant Acetate Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Icatibant Acetate Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Icatibant Acetate Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Icatibant Acetate Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Icatibant Acetate Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Icatibant Acetate Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Icatibant Acetate Injection
Table 52. Key Market Challenges & Risks of Icatibant Acetate Injection
Table 53. Key Industry Trends of Icatibant Acetate Injection
Table 54. Icatibant Acetate Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Icatibant Acetate Injection Distributors List
Table 57. Icatibant Acetate Injection Customer List
Table 58. Global Icatibant Acetate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Icatibant Acetate Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Icatibant Acetate Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Icatibant Acetate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Icatibant Acetate Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Icatibant Acetate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Icatibant Acetate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Icatibant Acetate Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Icatibant Acetate Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Icatibant Acetate Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Icatibant Acetate Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Takeda Pharmaceuticals Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
Table 74. Takeda Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Takeda Pharmaceuticals Main Business
Table 76. Takeda Pharmaceuticals Latest Developments
Table 77. Eugia Pharma Specialities Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolios and Specifications
Table 79. Eugia Pharma Specialities Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Eugia Pharma Specialities Main Business
Table 81. Eugia Pharma Specialities Latest Developments
Table 82. Glenmark Pharmaceuticals Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
Table 84. Glenmark Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Glenmark Pharmaceuticals Main Business
Table 86. Glenmark Pharmaceuticals Latest Developments
Table 87. Sandoz Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Sandoz Icatibant Acetate Injection Product Portfolios and Specifications
Table 89. Sandoz Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sandoz Main Business
Table 91. Sandoz Latest Developments
Table 92. Cipla Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Cipla Icatibant Acetate Injection Product Portfolios and Specifications
Table 94. Cipla Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Cipla Main Business
Table 96. Cipla Latest Developments
Table 97. Fresenius Kabi Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Fresenius Kabi Icatibant Acetate Injection Product Portfolios and Specifications
Table 99. Fresenius Kabi Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Fresenius Kabi Main Business
Table 101. Fresenius Kabi Latest Developments
Table 102. Jiangsu Hengrui Pharmaceuticals Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolios and Specifications
Table 104. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Jiangsu Hengrui Pharmaceuticals Main Business
Table 106. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 107. Chengdu Shengnuo Biology Pharmacy Basic Information, Icatibant Acetate Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolios and Specifications
Table 109. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Chengdu Shengnuo Biology Pharmacy Main Business
Table 111. Chengdu Shengnuo Biology Pharmacy Latest Developments
LIST OF FIGURES
Figure 1. Picture of Icatibant Acetate Injection
Figure 2. Icatibant Acetate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Icatibant Acetate Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Icatibant Acetate Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Icatibant Acetate Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Icatibant Acetate Injection Sales Market Share by Country/Region (2025)
Figure 10. Icatibant Acetate Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Icatibant Acetate Injection Sales Market Share by Type in 2026
Figure 14. Global Icatibant Acetate Injection Revenue Market Share by Type (2021-2026)
Figure 15. Icatibant Acetate Injection Consumed in Hospital and Clinic
Figure 16. Global Icatibant Acetate Injection Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Icatibant Acetate Injection Consumed in Pharmacy
Figure 18. Global Icatibant Acetate Injection Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Icatibant Acetate Injection Consumed in Other
Figure 20. Global Icatibant Acetate Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Icatibant Acetate Injection Sale Market Share by Application (2025)
Figure 22. Global Icatibant Acetate Injection Revenue Market Share by Application in 2026
Figure 23. Icatibant Acetate Injection Sales by Company in 2026 (K Units)
Figure 24. Global Icatibant Acetate Injection Sales Market Share by Company in 2026
Figure 25. Icatibant Acetate Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Icatibant Acetate Injection Revenue Market Share by Company in 2026
Figure 27. Global Icatibant Acetate Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Icatibant Acetate Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 30. Americas Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 32. APAC Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 34. Europe Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Icatibant Acetate Injection Sales Market Share by Country in 2026
Figure 38. Americas Icatibant Acetate Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Icatibant Acetate Injection Sales Market Share by Region in 2026
Figure 46. APAC Icatibant Acetate Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 49. China Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Icatibant Acetate Injection Sales Market Share by Country in 2026
Figure 57. Europe Icatibant Acetate Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Icatibant Acetate Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Icatibant Acetate Injection in 2026
Figure 74. Manufacturing Process Analysis of Icatibant Acetate Injection
Figure 75. Industry Chain Structure of Icatibant Acetate Injection
Figure 76. Channels of Distribution
Figure 77. Global Icatibant Acetate Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Icatibant Acetate Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Icatibant Acetate Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Icatibant Acetate Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Icatibant Acetate Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Icatibant Acetate Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Icatibant Acetate Injection
Figure 2. Icatibant Acetate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Icatibant Acetate Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Icatibant Acetate Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Icatibant Acetate Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Icatibant Acetate Injection Sales Market Share by Country/Region (2025)
Figure 10. Icatibant Acetate Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Icatibant Acetate Injection Sales Market Share by Type in 2026
Figure 14. Global Icatibant Acetate Injection Revenue Market Share by Type (2021-2026)
Figure 15. Icatibant Acetate Injection Consumed in Hospital and Clinic
Figure 16. Global Icatibant Acetate Injection Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Icatibant Acetate Injection Consumed in Pharmacy
Figure 18. Global Icatibant Acetate Injection Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Icatibant Acetate Injection Consumed in Other
Figure 20. Global Icatibant Acetate Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Icatibant Acetate Injection Sale Market Share by Application (2025)
Figure 22. Global Icatibant Acetate Injection Revenue Market Share by Application in 2026
Figure 23. Icatibant Acetate Injection Sales by Company in 2026 (K Units)
Figure 24. Global Icatibant Acetate Injection Sales Market Share by Company in 2026
Figure 25. Icatibant Acetate Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Icatibant Acetate Injection Revenue Market Share by Company in 2026
Figure 27. Global Icatibant Acetate Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Icatibant Acetate Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 30. Americas Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 32. APAC Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 34. Europe Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Icatibant Acetate Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Icatibant Acetate Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Icatibant Acetate Injection Sales Market Share by Country in 2026
Figure 38. Americas Icatibant Acetate Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Icatibant Acetate Injection Sales Market Share by Region in 2026
Figure 46. APAC Icatibant Acetate Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 49. China Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Icatibant Acetate Injection Sales Market Share by Country in 2026
Figure 57. Europe Icatibant Acetate Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Icatibant Acetate Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Icatibant Acetate Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Icatibant Acetate Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Icatibant Acetate Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Icatibant Acetate Injection in 2026
Figure 74. Manufacturing Process Analysis of Icatibant Acetate Injection
Figure 75. Industry Chain Structure of Icatibant Acetate Injection
Figure 76. Channels of Distribution
Figure 77. Global Icatibant Acetate Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Icatibant Acetate Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Icatibant Acetate Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Icatibant Acetate Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Icatibant Acetate Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Icatibant Acetate Injection Revenue Market Share Forecast by Application (2027-2032)
